The Cooper Companies, Inc. (COO)
NASDAQ: COO · IEX Real-Time Price · USD
89.66
+0.60 (0.67%)
May 1, 2024, 4:00 PM EDT - Market closed
The Cooper Companies Market Cap
The Cooper Companies has a market cap or net worth of $17.82 billion as of May 1, 2024. Its market cap has decreased by -6.53% in one year.
Market Cap
17.82B
Enterprise Value
20.53B
1-Year Change
-6.53%
Ranking
Category
Stock Price
$89.66
Market Cap Chart
Since December 1, 1998, The Cooper Companies's market cap has increased from $343.00M to $17.82B, an increase of 5,095.47%. That is a compound annual growth rate of 16.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 30, 2024 | 17.70B | -0.92% |
Apr 29, 2024 | 17.87B | 1.18% |
Apr 26, 2024 | 17.66B | -1.21% |
Apr 25, 2024 | 17.87B | -0.30% |
Apr 24, 2024 | 17.93B | -1.61% |
Apr 23, 2024 | 18.22B | 1.82% |
Apr 22, 2024 | 17.90B | -0.42% |
Apr 19, 2024 | 17.97B | 0.01% |
Apr 18, 2024 | 17.97B | 0.61% |
Apr 17, 2024 | 17.86B | -0.74% |
Apr 16, 2024 | 17.99B | -1.64% |
Apr 15, 2024 | 18.29B | -1.58% |
Apr 12, 2024 | 18.59B | -2.71% |
Apr 11, 2024 | 19.10B | -0.39% |
Apr 10, 2024 | 19.18B | -2.45% |
Apr 9, 2024 | 19.66B | 0.29% |
Apr 8, 2024 | 19.60B | 0.03% |
Apr 5, 2024 | 19.60B | -0.56% |
Apr 4, 2024 | 19.71B | 0.20% |
Apr 3, 2024 | 19.67B | 0.92% |
Apr 2, 2024 | 19.49B | -1.19% |
Apr 1, 2024 | 19.72B | -2.19% |
Mar 28, 2024 | 20.17B | -0.37% |
Mar 27, 2024 | 20.24B | 1.10% |
Mar 26, 2024 | 20.02B | -0.14% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Illumina | 19.82B |
Waters | 18.69B |
Genmab | 18.68B |
Alnylam Pharmaceuticals | 18.63B |
Hologic | 17.99B |
Laboratory Corporation of America Holdings | 17.17B |
BeiGene | 16.58B |
Teva Pharmaceutical | 15.81B |